Assessing the Clinical Influence of Chronic Total Occlusions (CTOs) Revascularization and the Impact of Vascularization Completeness on Patients with Left Ventricular (LV) Systolic Dysfunction
Table 3
Contrast of clinical results.
Variable
SCR (n = 128)
OMT (n = 117)
value
MACCE
39 (30.5)
60 (51.3)
0.001
All-cause death
17 (13.3)
28 (23.9)
0.033
Cardiac mortality
11 (8.6)
21 (17.9)
0.037
Rehospitalisation
21 (16.4)
54 (46.2)
<0.001
Heart failure
14 (10.9)
32 (27.4)
0.002
Target vessel revascularization
2 (1.6)
7 (6.0)
0.134
Recurrent myocardial infarction
4 (3.1)
8 (6.8)
0.239
Stroke
2 (1.6)
4 (3.4)
0.599
Variable
Complete revascularization (n = 41)
Incomplete revascularization (n = 87)
value
MACCE
7 (17.1)
32 (36.8)
0.025
All-cause death
2 (4.9)
15 (17.2)
0.091
Cardiac mortality
0 (0)
11 (12.6)
0.041
Rehospitalisation
6 (14.6)
15 (17.2)
0.802
Heart failure
2 (4.9)
12 (13.8)
0.228
Target vessel revascularization
1 (2.4)
1 (1.1)
1.000
Recurrent myocardial infarction
1 (2.4)
3 (3.4)
1.000
Stroke
0 (0)
2 (2.3)
0.83
Note. Data are expressed as numbers or proportions (%). Abbreviations: MACCE: major adverse cardiac and cerebrovascular events, a combination of ACD, cardiac mortality, relapse myocardium infarction, targeted vascular angiogenesis, rehospitalisation, cardiac failure, and stroke.
